These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35397262)

  • 1. The effect of Varenicline and Bupropion on smoking cessation: A network meta-analysis of 20 randomized controlled trials.
    Guo K; Wang S; Shang X; E F; Hou L; Li J; Li Y; Yang K; Li X
    Addict Behav; 2022 Aug; 131():107329. PubMed ID: 35397262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis.
    Guo K; Zhou L; Shang X; Yang C; E F; Wang Y; Xu M; Wu Y; Li Y; Li M; Yang K; Li X
    Drug Alcohol Depend; 2022 Dec; 241():109672. PubMed ID: 36332593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
    Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
    Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for promoting smoking cessation during pregnancy.
    Coleman T; Chamberlain C; Davey MA; Cooper SE; Leonardi-Bee J
    Cochrane Database Syst Rev; 2015 Dec; (12):CD010078. PubMed ID: 26690977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis.
    Wu P; Wilson K; Dimoulas P; Mills EJ
    BMC Public Health; 2006 Dec; 6():300. PubMed ID: 17156479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trials.
    Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo DM; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
    Addiction; 2022 Apr; 117(4):861-876. PubMed ID: 34636108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials.
    Rosen LJ; Galili T; Kott J; Goodman M; Freedman LS
    Addiction; 2018 May; 113(5):805-816. PubMed ID: 29377409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for smoking cessation and reduction in individuals with schizophrenia.
    Tsoi DT; Porwal M; Webster AC
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD007253. PubMed ID: 23450574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interventions on smoking cessation: A systematic review and network meta-analysis.
    Shang X; Guo K; E F; Deng X; Wang Y; Wang Z; Wu Y; Xu M; Yang C; Li X; Yang K
    Front Pharmacol; 2022; 13():1012433. PubMed ID: 36353488
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials.
    Suissa K; Larivière J; Eisenberg MJ; Eberg M; Gore GC; Grad R; Joseph L; Reynier PM; Filion KB
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28093398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis.
    Siskind DJ; Wu BT; Wong TT; Firth J; Kisely S
    Lancet Psychiatry; 2020 Sep; 7(9):762-774. PubMed ID: 32828166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis.
    Smith PH; Weinberger AH; Zhang J; Emme E; Mazure CM; McKee SA
    Nicotine Tob Res; 2017 Mar; 19(3):273-281. PubMed ID: 27613893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological interventions for promoting smoking cessation during pregnancy.
    Coleman T; Chamberlain C; Davey MA; Cooper SE; Leonardi-Bee J
    Cochrane Database Syst Rev; 2012 Sep; (9):CD010078. PubMed ID: 22972148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling continuous abstinence rates over time from clinical trials of pharmacological interventions for smoking cessation.
    Jackson SE; McGowan JA; Ubhi HK; Proudfoot H; Shahab L; Brown J; West R
    Addiction; 2019 May; 114(5):787-797. PubMed ID: 30614586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.
    Roberts E; Eden Evins A; McNeill A; Robson D
    Addiction; 2016 Apr; 111(4):599-612. PubMed ID: 26594837
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.